Population pharmacokinetics and pharmacodynamics of meropenem in elderly Chinese with lower respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229 Year: 2004
Efficacy and safety of Cefdinir in lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 420s Year: 2002
Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Telithromycin is as effective as comparator antibacterials in the treatment of lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 561s Year: 2002
Treatment of respiratory tract infections: comparison of telithromycin and azithromycin Source: Eur Respir J 2004; 24: Suppl. 48, 638s Year: 2004
Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007
Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009
Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002
Pharmacokinetics of consecutive oral moxifloxacin 400 mg/day in patients with respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Telithromycin is highly efficacious in the treatment of lower respiratory tract infections Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Antibiotic switch therapy in lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult patients with respiratory tract infections Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13 Year: 2004
Antibiotic resistance among patients with lower respiratory tract infections who have undergone empiric treatment Source: Eur Respir J 2006; 28: Suppl. 50, 787s Year: 2006
Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients Source: Eur Respir J, 53 (4) 1802107; 10.1183/13993003.02107-2018 Year: 2019
Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004
Streptococcal resistance to antibiotics in children with upper respiratory tract infections. Epidemiological aspects Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology Year: 2010